Contrast-enhanced endoscopic ultrasonography

World Journal of Gastroenterology

Volumn 17, Issue 1, 2011, Pages 42-48

  Reddy, Nischita K ^a   Ioncicǎ, Ana Maria ^b   Sǎftoiu, Adrian ^b   Vilmann, Peter ^c   Bhutani, Manoop S ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Contrast media; Doppler ultrasonography; Endoscopic ultrasonography; Gastrointestinal neoplasms; Pancreatic cancer

Indexed keywords

ALBUNEX; BISPHERE; CONTRAST MEDIUM; ECHOVIST; MYOMAP; PERFLEXANE; PERFLUBUTANE; PERFLUOROPENTANE; PERFLUTREN; QUANTISON; SHU 508; SONAVIST; SONOVUE; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY; CANCER INVASION; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DRUG MECHANISM; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS VARICES; GALLBLADDER CANCER; HUMAN; LYMPHADENOPATHY; MICROBUBBLE; PANCREAS CANCER; PORTAL VEIN; STOMACH CANCER; TUMOR VASCULARIZATION;

EID: 78651506511     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i1.42     Document Type: Article

References (48)

1. Keller MW, Feinstein SB, Watson DD. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. Am Heart J 1987; 114: 570-575
2. Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008; 6: 590-597.e1
3. Goldberg BB, Hilpert PL, Burns PN, Liu JB, Newman LM, Merton DA, Witlin LA. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990; 177: 713-717
4. Hirooka Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y, Kojima S, Hayakawa T, Naitoh Y. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998; 93: 632-635
5. Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y, Kojima S, Hashimoto S, Hayakawa T. Contrast- enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc 1998; 48: 406-410
6. Hocke M, Menges M, Topalidis T, Dietrich CF, Stallmach A. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol 2008; 134: 473-480
7. Kasono K, Hyodo T, Suminaga Y, Sugiura Y, Namai K, Ikoma A, Tamemoto H, Imawari M, Kawakami M, Ishikawa SE. Contrast-enhanced endoscopic ultrasonography improves the preoperative localization of insulinomas. Endocr J 2002; 49: 517-522
8. Nomura N, Goto H, Niwa Y, Arisawa T, Hirooka Y, Hayakawa T. Usefulness of contrast-enhanced EUS in the diagnosis of upper GI tract diseases. Gastrointest Endosc 1999; 50: 555-560
9. Straub JA, Chickering DE, Church CC, Shah B, Hanlon T, Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 2005; 108: 21-32
10. Klibanov AL. Ultrasound molecular imaging with targeted microbubble contrast agents. J Nucl Cardiol 2007; 14: 876-884
11. Maresca G, Summaria V, Colagrande C, Manfredi R, Calliada F. New prospects for ultrasound contrast agents. Eur J Radiol 1998; 27 Suppl 2: S171-S178
12. Karl-Jurgen Wolf FF. Color Duplex Sonography Principles and Clinical Applications. New York: Thieme Publishing Group, 1995
13. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17: 1995-2008
14. Greis C, Dietrich C. Ultrasound contrast agents and contrast- enhanced ultrasonography. In: Dietrich CF, editor. Endoscopic Ultrasound. An introductory manual and atlas. New York: Thieme Publishing Group, 2006: 44-57
15. Campbell SC, Cullinan JA, Rubens DJ. Slow flow or no flow? Color and power Doppler US pitfalls in the abdomen and pelvis. Radiographics 2004; 24: 497-506
16. Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13: 357-365
17. Dietrich CF, Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol 2005; 43: 1219-1223
18. Sanchez MV, Varadarajulu S, Napoleon B. EUS contrast agents: what is available, how do they work, and are they effective? Gastrointest Endosc 2009; 69: S71-S77
19. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis. Chest 2007; 131: 539-548
20. Yasuda I, Tsurumi H, Omar S, Iwashita T, Kojima Y, Yamada T, Sawada M, Takami T, Moriwaki H, Soehendra N. Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy 2006; 38: 919-924
21. Tournoy KG, Praet MM, Van Maele G, Van Meerbeeck JP. Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist: high accuracy for the diagnosis of mediastinal lymphadenopathy. Chest 2005; 128: 3004-3009
22. Kanamori A, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, Uchida H, Goto J, Ohmiya N, Niwa Y, Goto H. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol 2006; 101: 45-51
23. Nakase K, Yamamoto K, Hiasa A, Tawara I, Yamaguchi M, Shiku H. Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma. Cancer Detect Prev 2006; 30: 188-191
24. Hirooka Y, Naitoh Y, Goto H, Ito A, Taki T, Hayakawa T. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc 1997; 46: 166-169
25. Kitano M, Takagi T, Sakamoto H, Das K, Komaki T, Noda K, Yamao K, Kudo M. Dynamic imaging of pancreatic tumors by contrast-enhanced harmonic EUS with long-lasting contrast. Gastrointestinal Endoscopy 2009; 69: S228
26. Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol 2003; 38: 1155-1161
27. Wong RF, Tarcin O, Reddy N, Ahmed I, Brining D, Matsunaga TO, Bhutani MS. Contrast-enhanced EUS (CE-EUS) using a new microbubble contrast agent (MRX-815) - a feasibility study in a porcine model. Gastrointestinal Endoscopy 2006; 63: AB274
28. Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, Kanamori A, Ohmiya N, Niwa Y, Goto H. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005; 100: 144-152
29. Ohno E, Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ishikawa T, Ohmiya N, Niwa Y, Goto H. Usefulness of contrast-enhanced endoscopic ultrasonography (CE-EUS) in the diagnosis of mural nodule of intraductal papillary mucinous neoplasms of the pancreas. the comparison of the ce-eus findings with the pathological findings. Gastrointestinal Endoscopy 2008; 67: AB209
30. Zhu Q. Study on contrast enhanced EUS in differential diagnosis of pancreatic tumor. Gastrointestinal Endoscopy 2009; 69: S265
31. D'Onofrio M, Zamboni G, Tognolini A, Malago R, Faccioli N, Frulloni L, Pozzi Mucelli R. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 2006; 12: 4181-4184
32. Bhutani MS, Hoffman BJ, van Velse A, Hawes RH. Contrast- enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist). Endoscopy 1997; 29: 635-639
33. Becker D, Strobel D, Bernatik T, Hahn EG. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001; 53: 784-789
34. Ueno N, Tomiyama T, Tano S, Wada S, Aizawa T, Kimura K. Utility of endoscopic ultrasonography with color Doppler function for the diagnosis of islet cell tumor. Am J Gastroenterol 1996; 91: 772-776
35. Rickes S, Unkrodt K, Neye H, Ocran KW, Wermke W. Differentiation of pancreatic tumours by conventional ultrasound, unenhanced and echo-enhanced power Doppler sonography. Scand J Gastroenterol 2002; 37: 1313-1320
36. Giday SA, Canto MI, Magno P, Buscaglia J, Clarke J, Ko CW, Wroblewski L, Kalloo AN, Kantsevoy SV, Jagannath S. Contrast-enhanced endoscopic ultrasonography (CE-EUS) improves visualization of pancreatic vasculature. Gastrointestinal Endoscopy 2006; 63: AB266
37. Okamoto Y, Kawamoto H, Takaki A, Ishida E, Ogawa T, Kuwaki K, Kobayashi Y, Sakaguchi K, Shiratori Y. Contrastenhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors. Eur J Radiol 2007; 61: 163-169
38. Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006; 12: 246-250
39. Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Ohmiya N, Niwa Y, Goto H. Utility of contrast-enhanced endoscopic ultrasonography (CE-EUS) in the diagnosis of pancreatic diseases using perflubutane microbubbles. Gastrointestinal Endoscopy 2008; 67: AB214
40. Sakamoto H, Kitano M, Suetomi Y, Maekawa K, Takeyama Y, Kudo M. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008; 34: 525-532
41. Sofuni A, Iijima H, Moriyasu F, Nakayama D, Shimizu M, Nakamura K, Itokawa F, Itoi T. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005; 40: 518-525
42. Ernst H, Nusko G, Hahn EG, Heyder N. Color Doppler endosonography of esophageal varices: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. Endoscopy 1997; 29: S42-S43
43. Giday SA, Ko CW, Clarke JO, Shin EJ, Magno P, Jagannath SB, Buscaglia JM, Kantsevoy SV. EUS-guided portal vein carbon dioxide angiography: a pilot study in a porcine model. Gastrointest Endosc 2007; 66: 814-819
44. Ohshima T, Yamaguchi T, Ishihara T, Yoshikawa M, Kobayashi A, Sakaue N, Baba T, Yamada S, Saisho H. Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 2004; 28: 335-343
45. Lassau N, Brule A, Chami L, Benatsou B, Péronneau P, Roche A. [Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound]. J Radiol 2008; 89: 549-555
46. Lyshchik A, Fleischer AC, Huamani J, Hallahan DE, Brissova M, Gore JC. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrastenhanced high-frequency ultrasonography. J Ultrasound Med 2007; 26: 1575-1586
47. Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, Semmler W, Kiessling F. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 2008; 7: 101-109
48. Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008; 248: 936-944